NASDAQ:MNPR

Monopar Therapeutics Stock Predictions

etoro logo Buy MNPR
*Your capital is at risk
$60.56
-0.700 (-1.14%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

MNPR Prediction Chart

MNPR Predictions History

Latest community submissions for MNPR.
Predictor Target Session Target Price Result Direction Accuracy Score
Nov 18, 2024 Bearish $18.45 X 0
Nov 11, 2024 $15.63 -7.43% $16.66 V 93.80% 1
Nov 11, 2024 $16.10 -4.64% $16.66 V 96.62% 1
Nov 11, 2024 Bullish $16.66 X 0
Nov 1, 2024 $16.11 +10.54% $14.63 V 89.92% 1
Nov 1, 2024 $15.53 +6.59% $14.63 V 93.85% 1
thedean2010 thedean2010 Merchant
Nov 1, 2024 Bullish $14.63 V 1
Oct 30, 2024 $17.84 +10.06% $14.67 X 78.39% 0
Oct 30, 2024 $15.19 -6.29% $14.67 V 96.45% 1
Skagitqg Skagitqg Merchant
Oct 30, 2024 Bullish $14.67 X 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for MNPR with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT MONOPAR THERAPEUTICS INC.
Monopar Therapeutics
Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. Its lead product candidate in development is Validive, a clonidine hydrochloride mucobuccal tablet that is in Phase 2b/3 clinical trial for the prevention of chemoradiotherapy induced severe oral mucositis in patients with oropharyngeal cancer. The company also engages in developing Camsirubic...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE